The non-ergot derived dopamine agonist quinagolide in prevention of early hyperstimulation syndrome in IVF patients a randomized, double-blind, placebo-controlled trial - Busso,C.; Fernández-Sánchez,M.; Garćia-Velasco,J.A. (Hum Reprod, 2010)